On December 31 2019, MEDP has its mid-year review meeting at...
Mid-year review of MEDP concluded at IIC, New Delhi
On December 31 2019, MEDP has its mid-year review meeting at the Indian International Centre, New Delhi (Figure 4). The review was attended by the following participants:
I. Dr Amit Sharma, Director, ICMR NIMR New Delhi
II. Dr Altaf Lal, Director MEDP and Board member FDEC India
III. Dr Azadar Khan, Board member FDEC India
IV. Dr Suman Wattal, Dy. Director, NVBDCP New Delhi
V. Dr Ashwani Kumar, Director, VCRC Puducherry
VI. Dr Manju Rahi, Scientist F, ICMR HQs New Delhi
VII. Dr Anup Anvikar, Scientist F, ICMR NIMR New Delhi
VIII. Dr Abhinav Sinha, Scientist E, ICMR NIMR New Delhi
IX. Dr Praveen Bharti, Scientist E, ICMR NIRTH Jabalpur
X. Dr Satyendra Pandey, Consultant Entomologist, DHS Bhopal (nominated by Dr Himanshu Jayswar SPO DHS Bhopal)
XI. Mr Ramji Balavi, DMO Balaghat
XII. Dr Harsh Rajvanshi, Program Officer, MEDP Mandla
XIII. Mr Sekh Nisar, District Officer, MEDP Mandla
Key action points were discussed and identified as follows:
I. Fourth Malaria Elimination Advisory Group meeting in April 2020 – Dr Amit Sharma kindly accepted request for hosting this meeting at NIMR similar to last year.
II. Hemex at MEDP Mandla – Drs. Lal, Anvikar, and Bharti to facilitate introduction of ‘Hemex’ device in Mandla. Preferably, this should be tested in small geographical area for efficacy, cost-benefit analysis etc. before escalating to pan-district.
III. Improvement in district level coordination – Dr Satyendra Pandey assured support in improving coordinating with the state government at district level.
IV. Mass Drug Administration – Further discussions at the upcoming MEAG meeting to lay down the groundwork for MSAT followed by MDA in Mandla or neighbouring districts.
Mid-year review of MEDP concluded at IIC, New Delhi
On December 31 2019, MEDP has its mid-year review meeting at the Indian International Centre, New Delhi (Figure 4). The review was attended by the following participants:
I. Dr Amit Sharma, Director, ICMR NIMR New Delhi
II. Dr Altaf Lal, Director MEDP and Board member FDEC India
III. Dr Azadar Khan, Board member FDEC India
IV. Dr Suman Wattal, Dy. Director, NVBDCP New Delhi
V. Dr Ashwani Kumar, Director, VCRC Puducherry
VI. Dr Manju Rahi, Scientist F, ICMR HQs New Delhi
VII. Dr Anup Anvikar, Scientist F, ICMR NIMR New Delhi
VIII. Dr Abhinav Sinha, Scientist E, ICMR NIMR New Delhi
IX. Dr Praveen Bharti, Scientist E, ICMR NIRTH Jabalpur
X. Dr Satyendra Pandey, Consultant Entomologist, DHS Bhopal (nominated by Dr Himanshu Jayswar SPO DHS Bhopal)
XI. Mr Ramji Balavi, DMO Balaghat
XII. Dr Harsh Rajvanshi, Program Officer, MEDP Mandla
XIII. Mr Sekh Nisar, District Officer, MEDP Mandla
Key action points were discussed and identified as follows:
I. Fourth Malaria Elimination Advisory Group meeting in April 2020 – Dr Amit Sharma kindly accepted request for hosting this meeting at NIMR similar to last year.
II. Hemex at MEDP Mandla – Drs. Lal, Anvikar, and Bharti to facilitate introduction of ‘Hemex’ device in Mandla. Preferably, this should be tested in small geographical area for efficacy, cost-benefit analysis etc. before escalating to pan-district.
III. Improvement in district level coordination – Dr Satyendra Pandey assured support in improving coordinating with the state government at district level.
IV. Mass Drug Administration – Further discussions at the upcoming MEAG meeting to lay down the groundwork for MSAT followed by MDA in Mandla or neighbouring districts.Read More
As per NVBDCP’s National Strategic Plan for Malaria Elimin...
Focal sprays initiated by MEDP Mandla
As per NVBDCP’s National Strategic Plan for Malaria Elimination 2017-22, Indoor Residual Spray in the form of focal spray must be done in and around 50 houses of the malaria case where API is less than one and no vector control interventions like IRS or LLINs have been done. Till date, this was not being done in Mandla district. After extensive discussions with NVBDCP and GoMP, FDEC India took the responsibility of these focal sprays in the district. This month spray was completed in all the target villages
Focal sprays initiated by MEDP Mandla
As per NVBDCP’s National Strategic Plan for Malaria Elimination 2017-22, Indoor Residual Spray in the form of focal spray must be done in and around 50 houses of the malaria case where API is less than one and no vector control interventions like IRS or LLINs have been done. Till date, this was not being done in Mandla district. After extensive discussions with NVBDCP and GoMP, FDEC India took the responsibility of these focal sprays in the district. This month spray was completed in all the target villagesRead More
From December 5 to 7 2019, MEDP was showcased by ICMR NIRTH ...
MEDP showcased at the Chutka health and wellness festival by our partner – ICMR NIRTH.
From December 5 to 7 2019, MEDP was showcased by ICMR NIRTH as one of its flagship projects at the Chutka Health and Wellness festival in Mandla organized by the Ministry of AYUSH, Government of India. Participants were taught about malaria using the latest IEC BCC tools developed by the project following interactions of project field staff with community leaders and officers.
MEDP showcased at the Chutka health and wellness festival by our partner – ICMR NIRTH.
From December 5 to 7 2019, MEDP was showcased by ICMR NIRTH as one of its flagship projects at the Chutka Health and Wellness festival in Mandla organized by the Ministry of AYUSH, Government of India. Participants were taught about malaria using the latest IEC BCC tools developed by the project following interactions of project field staff with community leaders and officers.Read More
The MSAT exercise started in November 2019 around cryptic or...
Mass Screening and Treatment (MSAT) completed
The MSAT exercise started in November 2019 around cryptic or gametocyte positive cases were continued this month to cover all such cases for this year. This month, the target population was 1479 individuals, a coverage of 82.4% (1219) was achieved and no positive cases were found.
Mass Screening and Treatment (MSAT) completed
The MSAT exercise started in November 2019 around cryptic or gametocyte positive cases were continued this month to cover all such cases for this year. This month, the target population was 1479 individuals, a coverage of 82.4% (1219) was achieved and no positive cases were found.Read More
resources
filter by category
Publications
Tools
Reports
Significance of training, monitoring and assessment of malaria workers